Oncolytics Biotech Inc ONCY

Primary Symbol: T.ONC

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Not one, but two positive news items out today

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Oct 23, 2023 6:32pm

134 Views

Post# 35697259

RE:RE:RE:RE:RE:RE:Not one, but two positive news items out today

The goal is to be like you. A faceless, cowardly shill who spends his time trying to bring down a company that's trying to save people's lives. How do I become a price of garbage like that? Actively cheering on the demise of a business who's entire existence is to cure, mitigate or otherwise delay the death of a human being! That's what you do and if karma exists I imagine you've a hefty load coming your way.

<< Previous

Bullboard Posts

Next >>

Gold, growth and sustainability in focus for Mandalay Resources